Business Description
PsyBio Therapeutics Corp
NAICS : 541714
SIC : 3741
ISIN : CA6936971044
Share Class Description:
TSXV:PSYB.H: Ordinary SharesCompare
Compare
Traded in other countries / regions
PSYBF.USAPSYB.H.CanadaPSYB.Germany IPO Date
2021-02-25Description
PsyBio Therapeutics Corp is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of mental illness and neurological disorders.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.13 | |||||
| Equity-to-Asset | -5.97 | |||||
| Debt-to-Equity | -0.06 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 14-Day RSI | 52.64 | |||||
| 12-1 Month Momentum % | -66.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.05 | |||||
| Quick Ratio | 0.05 | |||||
| Cash Ratio | 0.01 | |||||
| Days Payable | 7513.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -46.91 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -529.33 | |||||
| ROIC % | -857.24 | |||||
| ROC (Joel Greenblatt) % | -2151.74 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.36 | |||||
| EV-to-EBITDA | -0.38 | |||||
| EV-to-FCF | -1.15 | |||||
| Earnings Yield (Greenblatt) % | -277.78 | |||||
| FCF Yield % | -94.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PsyBio Therapeutics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.04 | ||
| Beta | 0.88 | ||
| Volatility % | 46.71 | ||
| 14-Day RSI | 52.64 | ||
| 14-Day ATR (C$) | 0.000007 | ||
| 20-Day SMA (C$) | 0.01 | ||
| 12-1 Month Momentum % | -66.67 | ||
| 52-Week Range (C$) | 0.005 - 0.035 | ||
| Shares Outstanding (Mil) | 127.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PsyBio Therapeutics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PsyBio Therapeutics Corp Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
PsyBio Therapeutics Corp Frequently Asked Questions
What is PsyBio Therapeutics Corp(TSXV:PSYB.H)'s stock price today?
The current price of TSXV:PSYB.H is C$0.01. The 52 week high of TSXV:PSYB.H is C$0.04 and 52 week low is C$0.01.
When is next earnings date of PsyBio Therapeutics Corp(TSXV:PSYB.H)?
The next earnings date of PsyBio Therapeutics Corp(TSXV:PSYB.H) is .
Does PsyBio Therapeutics Corp(TSXV:PSYB.H) pay dividends? If so, how much?
PsyBio Therapeutics Corp(TSXV:PSYB.H) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers